HR 3694
To direct the Secretary of Health and Human Services, in consultation with the United States Trade Representative and other heads of Federal agencies, to submit to Congress a report on the impact of a waiver of certain obligations of member nations under the Agreement on Trade-Related Aspects of Intellectual Property Rights on global COVID-19 vaccine access, and for other purposes.
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill requires the Department of Health and Human Services to conduct a study and report to Congress on how a potential waiver of intellectual property rights under international trade agreements could affect global access to COVID-19 vaccines. The report will assess the impact on vaccine availability in the U.S. and worldwide, manufacturing capacity, supply chains, and investment in vaccine production. The U.S. Trade Representative is directed to oppose any such waiver if it would not increase vaccine access or negatively impact these factors.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.